Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
INFU 
InfuSystems Holdings Inc (INFU)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
10/28/2025: INFU (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $14
1 Year Target Price $14
| 4 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -31.88% | Avg. Invested days 34 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/28/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 213.45M USD | Price to earnings Ratio 41.8 | 1Y Target Price 14 |
Price to earnings Ratio 41.8 | 1Y Target Price 14 | ||
Volume (30-day avg) 4 | Beta 1.8 | 52 Weeks Range 4.61 - 11.04 | Updated Date 10/28/2025 |
52 Weeks Range 4.61 - 11.04 | Updated Date 10/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.25 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.63% | Operating Margin (TTM) 10.49% |
Management Effectiveness
Return on Assets (TTM) 6.73% | Return on Equity (TTM) 9.39% |
Valuation
Trailing PE 41.8 | Forward PE 30.03 | Enterprise Value 238487352 | Price to Sales(TTM) 1.53 |
Enterprise Value 238487352 | Price to Sales(TTM) 1.53 | ||
Enterprise Value to Revenue 1.7 | Enterprise Value to EBITDA 10.14 | Shares Outstanding 20425964 | Shares Floating 18040824 |
Shares Outstanding 20425964 | Shares Floating 18040824 | ||
Percent Insiders 6.86 | Percent Institutions 75.31 |
Upturn AI SWOT
InfuSystems Holdings Inc
Company Overview
History and Background
InfuSystems Holdings Inc. was founded to provide infusion therapy services, primarily focusing on oncology, pain management, and other specialty therapies. The company has evolved through organic growth and strategic acquisitions to expand its geographic reach and service offerings. Key milestones include expanding into new therapeutic areas and improving its IT and operational infrastructure.
Core Business Areas
- Infusion Services: Provides infusion pumps and related supplies and services for patients undergoing infusion therapy at home or in other outpatient settings. This includes managing the delivery, maintenance, and monitoring of infusion equipment.
- Direct to Physician Services: InfuSystems provides infusion solutions directly to physician practices and other healthcare providers, streamlining the delivery of specialty medications.
Leadership and Structure
The company has a board of directors overseeing executive management. The leadership team includes a CEO, CFO, and other senior executives responsible for various functional areas like operations, sales, and marketing. The organizational structure is hierarchical, with regional and departmental divisions.
Top Products and Market Share
Key Offerings
- Infusion Pumps and Supplies: Provides a range of infusion pumps and related supplies for various therapeutic needs, including oncology, pain management, and autoimmune diseases. Market share data is not readily available in the context of complete market. Major competitors include Option Care Health (OCRX) and BioScrip, Inc. (private)
- Therapy Management Services: Provides comprehensive therapy management services, including patient education, adherence monitoring, and clinical support. Market share is not readily available. Competitors include CVS Health (CVS) and Walgreens Boots Alliance (WBA), which have infusion service arms.
Market Dynamics
Industry Overview
The infusion therapy market is growing due to the increasing prevalence of chronic diseases, the shift towards home-based healthcare, and advancements in infusion technologies. The industry is competitive, with a mix of large national players and smaller regional providers.
Positioning
InfuSystems Holdings Inc. is positioned as a provider of comprehensive infusion therapy solutions, focusing on quality, reliability, and patient support. Their competitive advantages include its experienced clinical team and strong relationships with payers and providers.
Total Addressable Market (TAM)
The global infusion therapy market is expected to reach $33.1 billion by 2028. InfuSystems is positioned to capitalize on this growth, focusing on providing a comprehensive solution to its customers. The company is targeting the hospital as well as a direct to physician market.
Upturn SWOT Analysis
Strengths
- Established market presence
- Strong clinical expertise
- Comprehensive service offerings
- Focus on patient care
Weaknesses
- Limited brand recognition
- Dependence on key payers
- Relatively small scale compared to larger competitors
- Customer Acquisition and retention is a key challenge
Opportunities
- Expanding into new therapeutic areas
- Acquiring smaller competitors
- Leveraging technology to improve efficiency
- Partnerships to enhance geographical outreach
Threats
- Increasing competition
- Changes in reimbursement policies
- Technological advancements disrupting the market
- Economic downturn impacting healthcare spending
Competitors and Market Share
Key Competitors
- OCRX
- CVS
- WBA
Competitive Landscape
InfuSystems Holdings Inc. faces competition from larger national players like Option Care Health, CVS Health, and Walgreens Boots Alliance. It has a specialized approach, but scale is a challenge. Focus on particular clinical needs.
Growth Trajectory and Initiatives
Historical Growth: InfuSystems Holdings Inc. has demonstrated moderate growth in recent years, driven by increasing demand for infusion therapy services. Growth has been constrained by competitive pressures and reimbursement challenges.
Future Projections: Analysts project continued growth for InfuSystems Holdings Inc., driven by the aging population, increasing prevalence of chronic diseases, and expansion of home-based healthcare. Growth forecasts are subject to market conditions and company performance.
Recent Initiatives: Recent strategic initiatives undertaken by InfuSystems Holdings Inc. include: Expanding services to new geographic regions, investing in technology to improve operational efficiency, forming partnerships with healthcare providers.
Summary
InfuSystems Holdings Inc. is a niche player in the infusion therapy market. Growth has been steady but is limited by scale and profitability. It's strengths include its expertise and focus on patient care. Key challenges include increasing competition and evolving reimbursement policies.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry databases
- Market research reports
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered financial advice. Market conditions and company performance can change, impacting the accuracy of the information.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About InfuSystems Holdings Inc
Exchange NYSE MKT | Headquaters Rochester Hills, MI, United States | ||
IPO Launch date 2007-12-27 | President, CEO & Director Ms. Carrie A. Lachance B.S.N., M.B.A., R.N. | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 502 | Website https://www.infusystem.com |
Full time employees 502 | Website https://www.infusystem.com | ||
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates in two segments, Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.